NASDAQ
Revelation Biosciences, Inc. - Warrant (REVBW)
♥ 491 Thanks from members
Revelation Biosciences, Inc. (REVBW) reflects severe financial distress with high cash burn risks and a looming capital shortfall, juxtaposed against clinical developments for its Gemini-based kidney therapies and a newly approved Class J warrant structure.
No chart available for this instrument.